Tilaknagar Industries Q4 & FY26 Results: Volume Surges 135% YoY, Mansion House Hits 10 Mn Cases
Tilaknagar Industries reported strong Q4 FY26 results with volumes up 135% YoY to 8 million cases. FY26 volumes reached ~20 million cases, with Mansion House Brandy selling 10 million cases. Net revenue for Q4 FY26 was ₹949 crore and for FY26 was ₹2,346 crore. The company targets 16-18% EBITDA margin and debt reduction. A dividend of ₹1 per share is recommended.
The announcement includes substantial YoY growth figures, record brand performance, strategic expansion plans, and financial performance details, which are material to investors and indicate a significant positive development for the company.
The company reported significant YoY volume growth, record sales for a key brand, and strong revenue growth. The positive outlook for future targets and strategic expansions also contribute to a positive sentiment.
Tilaknagar Industries Limited (TI) has announced its audited financial results for the quarter and financial year ended March 31, 2026. The company reported a significant year-on-year (YoY) volume growth of 135% in Q4 FY26, reaching over 8 million cases for the combined business. For the full financial year FY26, the company achieved a sales volume of approximately 20 million cases, including four months of Imperial Blue (IB) under TI ownership. Mansion House Brandy recorded a record sale of 10 million cases in FY26, solidifying its position as India's largest Prestige & Above (P&A) brandy. The ex-IB business delivered a 14% growth in FY26 compared to FY25.
Q4 FY26 marked the first full quarter of IB operations under TI's ownership. The company's immediate targets for the next three years include achieving double-digit volume growth, an EBITDA margin of 16-18% on the combined business, reducing Net Debt/EBITDA to below 1.0x, and expanding the luxury and premium portfolio. TI has also exited the Transition Services and Manufacturing Agreement (TSMA) for approximately 75% of the IB business and has taken over manufacturing operations in these states, with plans to complete the transition in the remaining states over the next few quarters.
Financially, for Q4 FY26, TI reported a net revenue of ₹949 crore (YoY growth of 147.5%) and EBITDA of ₹146 crore with a 15.5% margin. For FY26, net revenue stood at ₹2,346 crore (YoY growth of 69.9%) and EBITDA at ₹352 crore with a 15.5% margin. The company's Board of Directors has recommended a dividend of ₹1 per equity share for FY 2025-26.
In other developments, TI has received government approval for an expanded capacity in Andhra Pradesh, increasing its capacity six-fold to 36 lakh cases per annum with a ₹59 crore capex investment. This expansion is expected to drive cost efficiencies and savings of approximately ₹10 crore annually. The company also highlighted its strategic investments and new launches, including Seven Islands Pure Malt Whisky and Monarch Legacy Edition, and its presence in luxury and super-premium segments across various categories. TI was also recognized among FinanceAsia’s Best Companies in India 2026 and received multiple awards for its brands and marketing initiatives.
What to do with a filing like this
Tilaknagar Industries Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Tilaknagar Industries Limited. Read the original for the full detail.